Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-14T04:31:39.295Z Has data issue: false hasContentIssue false
  • English
  • Français

Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine

Published online by Cambridge University Press:  15 May 2009

J. E. Cradock-Watson ,
Helen Macdonald ,
Margaret K. S. Ridehalgh ,
M. S. Bourne  and
Elise M. Vandervelde
J. E. Cradock-Watson
Affiliation:
Public Health Laboratory, Withington Hospital, Manchester M20 8LR
Helen Macdonald
Affiliation:
Public Health Laboratory, Withington Hospital, Manchester M20 8LR
Margaret K. S. Ridehalgh
Affiliation:
Public Health Laboratory, Withington Hospital, Manchester M20 8LR
M. S. Bourne
Affiliation:
University of Salford Student Health Service
Elise M. Vandervelde
Affiliation:
Virus Reference Laboratory, Central Public Health Laboratory, Colindale Avenue, London NW9 5HT
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The indirect immunofluorescent technique has been used to study the specific immunoglobulin responses in the sera of 63 non-immune adult women who received either Cendehill rubella vaccine subcutaneously, RA27/3 rubella vaccine subcutaneously, or RA27/3 vaccine intranasally. IgG, IgA and IgM antibodies increased virtually simultaneously, starting about 2 weeks after vaccination. IgG antibody appeared in all subjects and reached maximum titres 4–6 weeks after vaccination. The mean IgG titres elicited by the three different methods of vaccination did not differ significantly. IgA and IgM antibodies reached their highest titres between 21 and 28 days after vaccination and then declined to low or undetectable titres within about 9 weeks. The maximum IgA titres observed after intranasal administration of RA27/3 vaccine were significantly higher than those which occurred when the same vaccine was given subcutaneously, but no significant difference in IgM titres was observed. When unfractionated sera were examined IgA antibody was detected in 57 cases (91%) and IgM in 51 (81%). Fluorescent examination of fractions obtained by centrifugation on sucrose density gradients frequently revealed small amounts of IgA and IgM antibody which could not be detected by staining unfractionated serum, and with the inclusion of these results IgA antibody was detected in 61 cases (97%) and IgM in 59 (94%).

When 39 adults with pre-existing serum antibody were challenged with vaccine a definite IgA response was detected in only one subject and in no case was there any evidence of the appearance of IgM antibody.

Nasal antibody, consisting of IgG or IgA or both, was detected in 17 out of 23 non-immune subjects (74%) who received RA27/3 vaccine, either subcutaneously or intranasally. Titres were much lower than those which occur in the natural disease and there was no evidence that nasal antibody was elicited more readily by intranasal than by subcutaneous vaccination.

Type
Research Article
Information
Journal of Hygiene , Volume 73 , Issue 1 , August 1974 , pp. 127 - 141
Copyright
Copyright © Cambridge University Press 1974

References

REFERENCES

Bürgin-Wolff, A., Hernandez, R. & Just, M. (1971). Separation of rubella IgM, IgA and IgG antibodies by gel filtration on agarose. Lancet ii, 1278.CrossRefGoogle Scholar
Brown, G. C. & O'Leary, T. P. (1970). Fluorescent-antibody marker for vaccine-induced rubella antibodies. Infection and Immunity 2, 360.CrossRefGoogle ScholarPubMed
Cradock-Watson, J. E., Bourne, M. S. & Vandervelde, E. M. (1972). IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent technique. Journal of Hygiene 70, 473.CrossRefGoogle ScholarPubMed
Cradock-Watson, J. E., Ridehalgh, M. K. S., Bourne, M. S. & Vandervelde, E. M. (1973). Nasal immunoglobulin responses in acute rubella determined by the immunofluorescent technique. Journal of Hygiene 71, 603.CrossRefGoogle ScholarPubMed
Davis, W. J., Larson, H. E., Simsarian, J. P., Parkman, P. D. & MeyerH. M., Jr H. M., Jr (1971). A study of rubella immunity and resistance to infection. Journal of the American Medical Association 215, 600.CrossRefGoogle ScholarPubMed
Gupta, J. D., Peterson, V. J. & Murphy, A. M. (1972). Differential immune response to attenuated rubella virus vaccine. Infection and Immunity 5, 151.CrossRefGoogle ScholarPubMed
Horstmann, D. M., LiebhaberH., le H., leBouvier, G. L., Rosenberg, D. A. & Halstead, S. B. (1970). Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. New England Journal of Medicine 283, 771.Google Scholar
Mair, H. J. & Buchan, A. R. (1972). Rubella vaccination and termination of pregnancy. British Medical Journal iv, 271.Google Scholar
Ogra, P. L., Kerr-Grant, D., Umana, G., Dzierba, J. & Weintraub, D. (1971). Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. New England Journal of Medicine 285, 1333.CrossRefGoogle ScholarPubMed
Plotkin, S. A., Farquhar, J. D. & Ogra, P. L. (1973). Immunologic properties of RA27/3 rubella virus vaccine. Journal of the American Medical Association 225, 585.Google Scholar
Thompson, K. M. & Tobin, J. O'H (1970). Isolation of rubella virus from abortion material. British Medical Journal ii, 264.CrossRefGoogle Scholar
Vesikari, T., Vaheri, A. & Leinikki, P. (1971). Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus. Archiv für die gesamte Virusforschung 35, 25.CrossRefGoogle ScholarPubMed
Wyll, S. A. & Herrmann, K. L. (1973). Inadvertent rubella vaccination of pregnant women. Journal of the American Medical Association 225, 1472.CrossRefGoogle ScholarPubMed